Germany – Pharmaceutical products – Conclusion of non-exclusive rebate agreements pursuant to Section 130a(8) SGB V for the stated active substances, with the possibility of concluding agreements under the so-called open-house procedure.

Opportunity description

Kaufmännische Krankenkasse - KKH (hereinafter KKH) aims to conclude rebate agreements pursuant to Section 130a(8) SGB V with all suitable pharmaceutical companies for the active substance/the active substances under a so-called "open-house procedure." By specifying uniform contractual terms and conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the opportunity to conclude or accede to a rebate agreement pursuant to Section 130a(8) SGB V for the active substance named in the invitation to tender. Interested pharmaceutical companies may request the participation documents and the agreement from the stated contact address (rabattvertraege@kkh.de). Kaufmännische Krankenkasse - KKH (hereinafter KKH) aims to conclude rebate agreements pursuant to Section 130a(8) SGB V with all suitable pharmaceutical companies for the active substance (ATC) stated under BT-21-Lot and, where applicable, restricted to certain dosage forms under a so-called "open-house procedure." By specifying uniform contractual terms and conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies are offered the opportunity to conclude or accede to a rebate agreement pursuant to Section 130a(8) SGB V for the above-mentioned active substance. Interested pharmaceutical companies may request the participation documents and the agreement from the stated contact address. A prerequisite for concluding an agreement is that the interested pharmaceutical company submits the requested participation documents fully completed and signed. An agreement will be concluded with every pharmaceutical company that meets the conditions for participation. There is no exclusivity. Accession or conclusion of the agreement may take place at any time and under the same conditions. Individual contract negotiations will not be conducted. Should KKH conduct an invitation to tender for exclusive agreements for the active substances in the form of the open procedure during the term of the agreement, the agreements concluded under this publication will be terminated in accordance with the contractual provisions. Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.